Stock comparison
ELI LILLY & Co is 176.7x more valuable than LIGAND PHARMACEUTICALS INC by market capitalization ($1.142 T vs $6.47 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
LLY is larger
ELI LILLY & Co is 176.7x more valuable than LIGAND PHARMACEUTICALS INC by market capitalization ($1.142 T vs $6.47 B).
Market value leader
LLY
ELI LILLY & Co is 176.7x more valuable than LIGAND PHARMACEUTICALS INC by market capitalization ($1.142 T vs $6.47 B).
Revenue leader
LLY
LGND: $268.09M vs LLY: $65.18B.
Profit leader
LLY
LGND: $124.45M vs LLY: $20.64B.
Margin leader
LGND
LGND: 46.4% vs LLY: 31.7% net margin.
| Metric | LGND | LLY |
|---|---|---|
| Market cap | $6.47 B | $1.142 T |
| US-listed rank | #1233 | #10 |
| Revenue (latest FY) | $268.09M | $65.18B |
| Net income (latest FY) | $124.45M | $20.64B |
| Net margin | 46.4% | 31.7% |
| P/E (trailing FY) | 52.0x | 55.3x |
| SEC filings | 2,218 | 995 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
ELI LILLY & Co is 176.7x more valuable than LIGAND PHARMACEUTICALS INC by market capitalization ($1.142 T vs $6.47 B).
In their latest fiscal years, LIGAND PHARMACEUTICALS INC reported $268.09M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: LIGAND PHARMACEUTICALS INC and ELI LILLY & Co, or browse the full rankings.